Without this divesture, there is likely to be reduced competition among vaccine manufacturers in the U.S. and EU. The divesture is key to their $13.5 billion deal. So as to streamline Boehringer Ingelheim acquisition of Sanofi, the German pharmaceutical maker… Read More ›